RecruitingNAINTERVENTIONAL

Validation, in a Pediatric Population, of a French Translation of the MEPS/MEPI Score

This study is looking at a tool called the MEPI/MEPS score, which helps doctors understand children's elbow pain and how well their elbow moves. This score is used a lot around the world, even in French-speaking countries, to see how children are recovering after an elbow injury or surgery. However, the French version of this score has not been properly checked to make sure it works well for children. This study aims to do just that – to make sure the French version gives accurate and reliable results for young patients aged 4 to 17. The goal is to provide a better way for doctors to track a child's progress and rehabilitation.

At a glance

Status

Recruiting

Phase

Sponsor

Centre Hospitalier Universitaire, Amiens

Enrolment target

170

Start

13 Apr 2026

Estimated completion

01 Jul 2028

MEPI MEPS PREE DASH Elbow

What is this study about?

Imagine your child has an elbow injury. Doctors need a way to measure how much pain they have and how well they can use their arm. That's where scores like the MEPI/MEPS come in. These are like a checklist and questionnaire that help doctors track progress over time. This scoring system is really popular and used in many studies, especially for people who've had elbow injuries or operations.

Now, even though the MEPI/MEPS is used globally, including in places where French is spoken, the French translation of this specific score hasn't been properly tested to see if it works well for children. That's a bit like trying to use a growth chart designed for adults on a baby; it might not give the right information.

This study is all about making sure that the French version of the MEPI/MEPS score is accurate and reliable for children aged 4 to 17. By doing this, doctors will have a better, more trusted tool to understand how a child's elbow is healing and to make the best decisions about their care. It’s an important step to ensure children get the best possible follow-up for their elbow injuries.

Key takeaways

This study helps make a child's elbow pain and movement score reliable in French.
It aims to improve how doctors track recovery for children aged 4-17 with elbow issues.
No new medicines or treatments are given; it's about answering questions.
There are two groups: children with elbow injuries and children without.
Participation will involve completing a questionnaire/assessment during regular hospital visits.

Who may be eligible?

This study is looking for children aged between 4 and 17 years old. They are looking for two groups of children. One group will be children who have an elbow injury and are already being looked after at the hospital department.

The second group will be children who are also being seen at the same hospital department but do not have an elbow injury. Both groups need to be able to attend follow-up appointments as planned for the study.

Children cannot take part if they have difficulty understanding French, refuse to participate themselves, or if a parent or guardian says no. Also, if there's another health issue that would make it hard to properly check their elbow, they might not be able to join.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Is my child between 4 and 17 years old?
Is my child currently being seen at the hospital department?
Can my child understand and speak French?
Are we able to attend regular hospital appointments?
Are there any other health problems that might make it hard to check my child's elbow?

Answer every question to see your result.

What does participation involve?

If your child takes part, they will complete the French version of the MEPS/MEPI score. This involves answering questions about their elbow pain and how well they can move their arm, likely with some simple tasks. There are no medications involved in this study. The study looks at how your child is doing over a period of time, linked to their usual hospital appointments. The total duration of your child's participation will depend on their specific follow-up schedule as part of their regular care. You will be told upfront how many visits are expected.

Potential risks and benefits

Taking part in this study may help improve how doctors can measure children's elbow recovery in the future, which could benefit many other children. There are no known physical risks involved, as it simply involves answering questions and performing simple movements. The main 'risk' might be that it takes a little extra time during your child's hospital visits. You are free to withdraw your child from the study at any time, for any reason, without it affecting their medical care.

Locations (1)

CHU Amiens
Verified postcode
Amiens, France· Recruiting

Common questions

What is an MEPI/MEPS score?

It's a questionnaire and simple test that helps doctors measure a child's elbow pain and how well their arm moves after an injury or surgery.

Why is this study needed?

The French version of this score hasn't been properly checked to make sure it works accurately for children, so this study aims to do that.

Will my child have to take any medicine?

No, this study does not involve any medicines or treatments. It's only about completing questionnaires and simple tests.

How long will my child be in the study?

Your child's involvement will fit around their regular hospital appointments, and the exact length of time will be explained to you.

Can we stop participating at any time?

Yes, you can choose to withdraw your child from the study at any point, and it won't affect their medical care.

How to find out more

Céline KLEIN, Pr

klein.celine@chu-amiens.fr 33+3 22 08 80 00 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.